List Of Titles

Showing items 1 - 2 of 2

Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study

- Shapiro, Jeremy D., Thavaneswaran, Subotheni, Tebbutt, Niall C., Price, Timothy J., Khasraw, Mustafa, Van Hazel, Guy A., Waring, Paul M., Tejpar, Sabine, Simes, John, Gebski, Val J., Desai, Jayesh, Segelov, Eva, Underhill, Craig R., Robledo, Kristy P., Karapetis, Chistos S., Day, Fiona L., Nott, Louise M., Jefford, Michael, Chantrill, Lorraine A., Pavlakis, Nick

Creator: Shapiro, Jeremy D. , Thavaneswaran, Subotheni , Tebbutt, Niall C. , Price, Timothy J. , Khasraw, Mustafa , Van Hazel, Guy A. , Waring, Paul M. , Tejpar, Sabine , Simes, John , Gebski, Val J. , Desai, Jayesh , Segelov, Eva , Underhill, Craig R. , Robledo, Kristy P. , Karapetis, Chistos S. , Day, Fiona L. , Nott, Louise M. , Jefford, Michael , Chantrill, Lorraine A. , Pavlakis, Nick
Resource Type: journal article
Date: 2018

Quick View

1

‹ › ×